Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia

It was recently recognized that some chronic myeloid leukemia patients with a complete molecular response could sustain that response after discontinuation of imatinib. To characterize the clinical outcomes and profiles of chronic phase chronic myeloid leukemia patients who could discontinue imatini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Takahashi, Naoto, Kyo, Taiichi, Maeda, Yasuhiro, Sugihara, Takashi, Usuki, Kensuke, Kawaguchi, Tatsuya, Usui, Noriko, Okamoto, Shinichiro, Ohe, Yokiko, Ohtake, Shigeki, Kitamura, Kunio, Yamamoto, Masahide, Teshima, Hirofumi, Motoji, Toshiko, Tamaki, Toshiharu, Sawada, Kenichi, Ohyashiki, Kazuma
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2012
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366657/
https://ncbi.nlm.nih.gov/pubmed/22180435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.056853
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados